[ad_1]
Check your eye drops. Again.
Multiple batches of Purely Soothing 15% MSM Drops are being recalled over concerns over “non-sterility,” which means that they could cause eye infections. And it’s the latest in a string of eye drop recalls.
This time, Pharmedica USA LLC, recently shared the voluntary recall of Purely Soothing drops on the Food and Drug Administration‘s recalls and safety alerts site, and urged people to stop using these eye drops immediately.
“Use of contaminated eye drops can result in the risk of eye infections that could result in blindness,” the statement said.
Check your eye drops label to see whether your product is the one involved in the recall. It would read: LOT#: 2203PS01, 1 oz, UPC 7 31034 91379 9; or LOT#: 1808051, ½ oz, UPC 7 31034 91382 9. The product includes eye dropper caps and white lids. Or, an image of the eye drops being recalled can be found below.
The Purely Soothing 15% MSM Drops are being recalled over non-sterility concerns that could cause infection.
FDA
Pharmedica USA says it has not received any complaints about the eye drops as of yet, and is conducting the recall voluntarily. But the company added that consumers should contact their physician or healthcare provider if they experience any problems that may be related to taking or using these drops.
The eye drops, which are an anti-inflammatory meant to treat eye irritation and/or swelling, were sold worldwide via the company’s website and other big online e-commerce platforms including Amazon
AMZN,
the company says.
See also: Diabetes and obesity rates are rising among young adults in the U.S., new study finds
Shoppers with more questions about the recall, or who are unsure whether their product is among those impacted, should contact Pharmedica USA by phone at (623)-698-1752 or through email at osm@pharmedicausa.com.
There was no mention of refunds or item exchanges in the company’s press release.
There have been a few eye drop recalls recently, including one last week from Florida’s Apotex Corp., which was also over sterility concerns. That voluntary recall for select lots of Brimonidine Tartrate Ophthalmic Solution, 0.15% was made “out of an abundance of caution due to cracks that have developed in some of the units caps,” according to the retail notice.
Global Pharma Healthcare also issued a recall of its EzriCare Artificial Tears in February after the product was linked to an outbreak of drug-resistant bacterial infections, including some found in blood, urine and lungs. The Centers for Disease Control and Prevention said the outbreak linked to EzriCare drops, which are made in India, impacted 55 people in 12 states. One person died, and five suffered permanent vision loss.
Read more: Eye drops recalled after drug-resistant bacteria outbreak linked to at least one death
The FDA recommended the recall based on manufacturing problems including lack of testing and proper controls on packaging. And the agency also blocked importing the drops into the United States.
[ad_2]
Source link
